Jump to ContentJump to Main Navigation
OSH Fetal Cardiology

Nick Archer, Nicky Manning

Publisher:
Oxford University Press
Print Publication Date:
Jul 2009
Print ISBN-13:
9780199230709
Published to Oxford Medicine:
Oct 2011
DOI:
10.1093/med/9780199230709.001.0001

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Conclusion

Chapter:
Conclusion
Author(s):

Nick Archer,

Nicky Manning

DOI:
10.1093/med/9780199230709.003.0025

Conclusion

Fetal cardiology is progressing extremely rapidly. It is certain that by the time this book is published some new information will be threatening to alter some aspects of diagnosis or management. We have deliberately not speculated about details of possible new approaches. The clinical role of 3D and 4D scanning, of some of the newer Doppler techniques, and of fetal ECG for example, will become clearer in time, particularly with respect to assessing fetal cardiac function. Indications for and value of fetal cardiac interventions are being actively evaluated. Drug therapy for fetal conditions in addition to arrhythmias is only in its infancy with no clear consensus at present—this will change.

New developments will not remove the challenge to continue to improve knowledge of and practical ability to detect and define structural abnormalities of the heart.